UPC scenario 5: Enforcing a patent inside and outside the UPC
In the latest in our series of UPC scenarios, Laura Whiting and Inmaculada Lorenzo explore the options for a pharmaceutical patent owner faced with a potential infringer manufacturing its product in Spain
Innovator pharmaceutical companies seeking to keep first entrant generic competitors off the market for a blockbuster drug are frequent litigators before the national patent courts of Europe. With the advent of the Unitary Patent and Unified Patent Court (UPC) –...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.